Faculty - Health Policy and Management

Fauzia Aman Malik PhD, MSc. is the Special Advisor to the Dean for Global Health Research and Initiatives at the Yale School of Public Health, and an Associate Research Scientist at the Department of Health Policy and Management. Born and raised in Pakistan, Fauzia has been living and working on four continents in global health for the past 20 years. As a trained Medical Anthropologist, she specializes in ethnographic, participatory mixed methods research, and designing and evaluation of community-based health programs that address the needs of vulnerable populations. As part of an academia, she has worked closely with organizations like National Institute of Health, Bill and Melinda Gates Foundation, Centers for Disease Control, the World Bank, German Development Agency (GTZ), GAVI, IVI, Sabin Institute, UNICEP, UNFPA, and local and international NGOs.

Fauzia's research is focused on health disparities and access to care, most recently for people living with HIV in the era of the Affordable Care Act (ACA) - the 2010 health reform. In this ethnographic work, she investigated how the ACA policy became implementable into day to day life of an HIV clinic funded by the Ryan White Care Act and providing care within the fragmented American healthcare system, how these policies translate access to care into lived experience for people living with HIV, and how this ‘social life of health policy’ informs, directs, and re-directs the strategic processes of providing care, policy-making, organizational culture, and social change. 

A substantial portion of Fauzia's research portfolio includes work on improving acceptance and uptake of vaccines for pregnant women and their children in Pakistan, Kenya, Honduras, Argentina, Peru, Brazil, Mexico, and the United States. Her most recent work includes studying social mixing patterns in corporate workplace (US) and community setting (Mozambique, Guatemala, India, and Pakistan) to model and assess the effectiveness of various social distancing strategies in reducing the transmission of pandemics such as COVID-19 and influenza. Other pandemic related projects focus on developing behavioral interventions addressing COVID-19 vaccine misinformation, acceptance, and uptake for adults and children in Pakistan and Chad. 

In addition to project development and research, Fauzia has mentored and supervised student's research and taught several graduate and undergraduate level courses on qualitative research methods and analysis, community-based participatory action research, critical issues in global health and anthropology and international health. She is regularly trainings research teams on research design, data collection and analysis methods, streamlining implementation, and monitoring and evaluation of the projects. 

Rene Almeling is associate professor of sociology at Yale University with research and teaching interests in gender and medicine. Using a range of qualitative, historical, and quantitative methods, she examines questions about how biological bodies and cultural norms interact to influence scientific knowledge, medical markets, and individual experiences. She is the author of Sex Cells, an award-winning book that offers an inside look at the American market for egg donors and sperm donors. Her latest book, GUYnecology, examines why there is so little attention to men’s reproductive health and analyzes how this gap affects medical knowledge, health policy, and reproductive politics.

Professor Almeling has also conducted two original surveys, the first on Americans’ attitudes toward genetic risk (with political scientist Shana Kushner Gadarian) and the other on women’s bodily experiences ofin vitrofertilization. With Sebastian Mohr, she is co-editor of a double special issue on “Men, Masculinities, and Reproduction” (2020). She has received funding for her research from the National Science Foundation and the Robert Wood Johnson Foundation. Her articles have appeared inAmerican Sociological Review,Annual Review of Sociology,Journal of Health and Social Behavior, andGender & Society. She is a recipient of the Arthur Greer Memorial Prize for Outstanding Scholarly Research, one of Yale’s highest honors, and holds courtesy appointments in American Studies, the Yale School of Public Health (Department of Health Policy and Management), and the Yale School of Medicine (Section of the History of Medicine). During the 2019-20 academic year, she was a fellow at the Center for Advanced Study in Behavioral Sciences at Stanford University.

More information is available at www.renealmeling.com.

Dr. Fiellin has focused his scholarly work on the interface between primary care, general healthcare settings and addiction. He is an Internal Medicine physician Board Certified in Addiction Medicine.  He serves as the inaugural Director of the Yale Program in Addiction Medicine. He conducts research on the transfer of treatments for opioid use disorder and alcohol use disorder from specialized settings to office-based, primary care, Emergency Department and HIV specialty settings. He has served as Principal Investigator on multiple NIH-funded research clinical trials, observational studies and implementation science. He has received awards from the American Association for the Treatment of Opioid Dependence,  the American Society of Addiction Medicine, AMERSA and the  the Hazelden-Betty Ford Foundation. He is on the Editorial Boards of the Journal of Addiction Medicine, Journal of Substance Abuse Treatment, and Substance Abuse and is Co-Editor of Alcohol, Other Drugs & Health: Current Evidence and the Principles of Addiction Medicine, 4th, 5th and 6th Editions. He has served on the Board of Directors of the College on Problems of Drug Dependence and as Co-Chair of the Substance Abuse Task Force for the Society of General Internal Medicine.

Alan Gerber is Professor of Political Science and Director of the Center for the Study of American Politics at Yale University where he teaches courses on experimental methods, statistics, and American politics. His current research focuses on the application of experimental methods to the study of campaign communications, and he has designed and performed experimental evaluations of many campaigns and fundraising programs, both partisan and non-partisan in nature.

His experimental research has appeared in numerous academic journals including the leading journals in political science: the American Political Science Review, American Journal of Political Science, and the Journal of Politics, as well as the Proceedings of the National Academy of Science. He currently serves as an editor of the Quarterly Journal of Political Science.

He has received various academic honors and awards, including the Heinz Eulau Award for the best article in the American Political Science Review (2002), and was recently selected to be a fellow-in-residence at the Center for Advanced Studies in the Behavioral Sciences (2004-2005).

Dr. Justice is a Clinical Epidemiologist who has developed multiple large national cohorts based on data from the Veterans Affairs Healthcare System Electronic Medical Record enhanced with National Death Index and CMS data, patient completed surveys, DNA and tissue repositories, and stored pathology samples. She has two decades of experience in the processes required to clean, validate, and standardize raw EMR data and in its analysis using standard statistical methods, machine learning techniques, and cross cohort validations. The oldest and best known of her projects is the Veterans Aging Cohort Study (VACS). VACS is an ongoing, longitudinal study of >170,000 United States veterans with and without HIV infection continuously funded by National Institutes of Health (NIH) since 1996. She has developed and validated widely used indices including a prognostic index, the VACS Index, and a patient reported symptom index, the HIV Symptom Index. She is the principal investigator of the National Cancer Institute provocative questions grant HIV and Aging Mechanisms for Hepatocellular Cancer, has published over 400 peer reviewed manuscripts, and has presented work at the United Nations, The International AIDS Society, The Royal Medical College in London, the White House, and Congress. She is a member of the National Cancer Institute Ad hoc Subcommittee on HIV and AIDS Malignancy and the HIV and Aging Working Group, NIH Office of AIDS Research. She has recently joined the International Advisory Boards of Lancet HIV and Journal of the International AIDS Society.  

Edward H. Kaplan obtained his BA from McGill University with First Class Honors in Economic and Urban Geography, and proceeded to graduate study at the Massachusetts Institute of Technology where he completed three masters’ degrees (in Operations Research, City Planning, and Mathematics) in addition to his doctorate in Urban Studies. He currently serves as the William N. and Marie A. Beach Professor of Management Sciences at the Yale School of Management, Professor of Public Health at the Yale School of Medicine, and Professor of Engineering in the Yale School of Engineering and Applied Sciences. An elected member of both the National Academy of Engineering (2003) and the Institute of Medicine (2004), Kaplan is an expert in operations research, mathematical modeling and statistics who studies problems in public policy and management. His recent research has focused on counterterror topics such as the tactical prevention of suicide bombings, bioterror preparedness, and response logistics in the event of a smallpox or anthrax attack. His work on smallpox was awarded the 2003 Koopman Prize of the Institute for Operations Research and the Management Sciences (INFORMS) Military Applications Society, while his models evaluating suicide-bomber-detector schemes received the same award in 2005. Kaplan serves on the National Academy of Sciences panel on basic research to improve intelligence analysis, and co-directs the Daniel Rose Technion-Yale Initiative in Homeland Security and Counter Terror Operations Research. Kaplan has also conducted award-winning research that evaluates the effectiveness of HIV prevention programs while developing new mathematical models for the study of HIV transmission, prevention, and resource allocation. His empirical and modeling research demonstrating the effectiveness of New Haven’s needle exchange program remains among the most creative and important examples of HIV prevention program evaluation to date. Honors for his HIV-related research include induction into the Omega Rho operations research honor society in 2000, the 2002 INFORMS President’s Award recognizing work that advances the welfare of society, the 1997 Ira Hiscock Award of the Connecticut Public Health Association, the 1994 Lanchester Prize for the best publications in the operations research literature, the 1992 Franz Edelman Award for management science achievement, the 1991 State of Connecticut Health Department’s AIDS Leadership Award, the 2009 Charles C. Shepard Science Award from the Centers for Disease Control, and the INFORMS Philip Morse Lectureship for 2010-11. Kaplan served twice as the Lady Davis Visiting Professor at the Hebrew University of Jerusalem—in the School of Public Health and Community Medicine in 1994, and in the Department of Statistics in 1997 -- and is also an elected member of the Board of Governors of the Technion-Israel Institute of Technology. For all of his contributions to the operations research profession, Kaplan was designated an INFORMS Fellow in November 2005.

Professor Kings' research examines factors associated with the adoption, diffusion, and utilization of mental health medications. In general, her research analyzes the spatial and temporal dimensions of innovation and contagion. To understand how large-scale social transformations arise from local social networks, she has studied cases ranging from the rise in autism prevalence during the past decade to the organizational foundations of the antislavery movement in the late 19th century. Her research appears in journals such as American Sociological Review, American Journal of Sociology, and Administrative Science Quarterly.

Harlan Krumholz is a cardiologist and scientist at Yale University and Yale New Haven Hospital. He is the Harold H. Hines, Jr. Professor of Medicine. He is a leading expert in the science to improve the quality and efficiency of care, eliminate disparities and promote equity, improve integrity and transparency in medical research, engage patients in their care, and avoid wasteful practices. Recent efforts are focused on harnessing the digital transformation in healthcare to accelerate knowledge generation and facilitate the delivery of care aligned with each patient’s needs and preferences.

Dr. Krumholz is director of the Yale New Haven Hospital Center for Outcomes Research and Evaluation (CORE), an organization dedicated to improving health and health care through research, tools, and practices that produce discovery, heighten accountability and promote better public health and clinical care. He co-founded and co-leads the Yale University Open Data Access (YODA) Project, designed to increase access to clinical research data and promote their use to generate new knowledge. He also co-founded and co-leads medRxiv, a non-profit preprint server for the medical and health sciences. He was a founding faculty co-director of the Yale Center for Research Computing.

Dr. Krumholz has been honored by membership in the National Academy of Medicine, the Association of American Physicians, and the American Society for Clinical Investigation. He was named a Distinguished Scientist of the American Heart Association and received their Award of Meritorious Achievement and their Clinical Research Prize. He served as a member of the Advisory Committee to the Director of the National Institutes of Health. Dr. Krumholz received the Friendship Award from the People’s Republic of China in recognition of his collaborative efforts to develop a national cardiovascular research network and was named by the Chinese Society of Cardiology as a Top-10 Distinguished International Cardiologist for his contributions to the development of cardiovascular medicine in China. He founded the American Heart Association’s Quality of Care and Outcomes Research Council and co-founded their annual conference. He was the founding editor of Circulation: Cardiovascular Quality and Outcomes; founding editor of CardioExchange, a social media site of the publisher of the New England Journal of Medicine; and editor of Journal Watch Cardiology of the New England Journal of Medicine. He was a founding Governor of the Patient-Centered Outcomes Research Institute.

He is a co-founder of HugoHealth, a patient-centric platform to engage people as partners in research and clinical care, facilitate the secure acquisition and movement of digital health data, and promote learning health communities. He is a co-founder of Refactor Health, an enterprise healthcare AI-augmented health data management company.

Before joining the Yale faculty in 1992, Dr. Krumholz received a BS (Biology) from Yale, an MD from Harvard Medical School, and a Masters in Health Policy and Management (SM) from the Harvard University School of Public Health. At Yale, he directed the Robert Wood Johnson Foundation Clinical Scholars Program from 1996-2017 and serves as Director Emeritus of the Yale National Clinician Scholars Program. Dr. Krumholz has published more than 1000 articles and three books and has an h-index of more than 200. 

Professor Pinker’s research in healthcare looks at questions related to patient flow and capacity management within both in-patient and out-patient settings. In the out-patient setting he has studied the division of labor in primary care practices and advanced access appointment scheduling systems. In the in-patient setting he has studied how bed configurations can impact access to care and how congestion in ICUs impacts patient flow. He is currently involved in several projects investigating the use of the Rothman Index as a predictive tool to inform clinical decision making. Outside of healthcare he has done research on service supply chains, the use of flexible workforces, online auctions and responses to terrorist threats among others. He serves on the editorial boards of several leading journals in his field. Pinker has consulted for the United States Postal Service, the financial services industry and the auto industry. His work has been published in leading journals such as Operations Research, Management Science, Manufacturing and Service Operations Management, IIE Transactions, Production and Operations Management, and the Communications of the Association of Computing Machinery.

Dr. Robert Rosenheck is Professor of Psychiatry, Public Health and at the Child Study Center at Yale Medical School where he is also Director of the Division of Mental Health Services and Outcomes Research in the Department of Psychiatry. He is an internationally known mental health service researcher who is leader in cost-effectiveness studies of behavioral health interventions and in monitoring quality of care and other aspects of the performance of large health care system. He was responsible for the cost-effectiveness components of the recent NIMH-funded Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia and Alzheimer’s disease trials as well as five multi-site VA Cooperative Studies. As founding Director of the Department of Veterans Affairs Northeast Program Evaluation Center he spent 22 years evaluating, disseminating, and monitoring innovative mental health programs across the VA system including: (i) several hundred specialized programs for homeless veterans; (ii) a national network of 100 Assertive Community Treatment (ACT) teams for veterans who suffer from severe and persistent mental illnesses; (iii) a variety of specialized programs for veterans suffering from war-related PTSD and iv. a national network of work restoration programs. Beginning in 1994 he published the annual Mental Health Report Card for the Department of Veterans Affairs (see http://NEPEC.med.VA.gov) He was a prime architect of national VA collaborative programs with both the Department of Housing and Urban Development and the Social Security Administration. He also directed both the client-level evaluation of the ACCESS program for homeless mentally ill Americans, for the Substance Abuse and Mental Health Services Administration of the Department of Health and Human Services and the joint HUD-HHS-VA Collaborative Initiative on Chronic Homelessness. He has published more than 850 scientific papers on topics such as performance evaluation of large mental health systems, mental health quality of care, the causes of homelessness, the organization and financing of mental health services, and the cost-effectiveness of psychosocial and psychopharmacological treatments of serious mental illness, homelessness, and PTSD among war veterans. He has conducted global mental health services research in China, Brazil, Nigeria, and Ghana. He has received awards for his work from the American Psychiatric Association and the American Public Health Association, among others

Joseph S. Ross, MD, MHS, is a Professor of Medicine (General Medicine) and of Public Health (Health Policy and Management), a member of the Center for Outcomes Research and Evaluation (CORE) at the Yale-New Haven Hospital, and an Co-Director of the National Clinician Scholars program (NCSP) at Yale. He completed his undergraduate degrees in biological science: neuroscience and psychology at the University of Rochester and his medical degree at the Albert Einstein College of Medicine, Bronx, NY. After completing his post-graduate training in primary care internal medicine at Montefiore Medical Center in Bronx, NY, Dr. Ross was a fellow in the Robert Wood Johnson Foundation Clinical Scholars program at Yale, earning a Master’s degree in health sciences research. Using health services research methods, Dr. Ross’s research focuses on examining factors which affect the use or delivery of recommended ambulatory care services for older adults and other vulnerable populations, evaluating the impact of state and federal policies on the delivery of appropriate and higher quality care, and issues related to pharmaceutical and medical device regulation, evidence development, postmarket surveillance, and clinical adoption. In addition, he collaborates with a multi-disciplinary team of investigators under contract for the Centers for Medicare and Medicaid Services to develop statistical models that are used to measure and publicly report hospital and ambulatory care clinical outcomes using administrative data. Dr. Ross co-directs the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI), the Yale Open Data Access (YODA) Project, the Collaboration for Research Integrity and Transparency (CRIT) at Yale Law School, and leads efforts at Yale-New Haven Health System in collaboration with the National Evaluation System for health Technology (NEST). Dr. Ross is currently the U.S. Outreach and Research Editor at BMJ.

Fiona M. Scott Morton is the Theodore Nierenberg Professor of Economics at the Yale University School of Management where she has been on the faculty since 1999. Her area of academic research is empirical industrial organization, with a focus on empirical studies of competition in areas such as pricing, entry, and product differentiation. Her published articles range widely across industries, from magazines, to shipping, to pharmaceuticals, to internet retailing, and are published in leading economics journals. From 2011-12 Professor Scott Morton served as the Deputy Assistant Attorney General for Economics at the Antitrust Division of the U.S. Department of Justice, where she helped enforce the nation’s antitrust laws. At Yale SOM she teaches courses in the area of competitive strategy.

Dr. Unni Karunakara was International President of Médecins Sans Frontières / Doctors Without Borders (MSF) from 2010-2013. He has been a humanitarian worker and a public health professional for more than two decades, with extensive experience in the delivery of health care to populations affected by conflict, disasters, epidemics, and neglect in Africa, Asia, and the Americas. He was Medical Director of the MSF’s Campaign for Access to Essential Medicines (2005-2007) and co-founded VIVO, an organisation that works toward overcoming and preventing traumatic stress and its consequences. Karunakara serves on the Board of Directors of Drugs for Neglected Diseases Initiative (DNDi) India and MSF Holland.  

Dr Karunakara was a Senior Fellow of the Jackson Institute for Global Affairs at Yale University from 2014-2017. He has held various academic and research fellowships at universities in South Africa, Zimbabwe, Uganda, Germany and the United Kingdom, focusing on the demography of forced migration and the delivery of health care to neglected populations affected by conflict, disasters and epidemics. Karunakara served as the Deputy Director of Health of the Earth Institute, Millennium Villages Project (2008-2010), and was Assistant Clinical Professor at the Mailman School of Public Health (2008-2017), both at Columbia University. Karunakara is a Visiting Professor at Manipal University.

Marna P. Borgstrom, ’79 M.P.H. began her career at Yale New Haven Hospital over 37 years ago. Her varied roles have taken her form post-graduate fellowship, to various staff and management roles, to her promotion in 1994 to the position of Executive Vice President and Chief Operating Office at Yale New Haven Hospital. In 2005, she assumed the position of CEO of Yale New Haven Hospital & CEO of Yale New Haven Health and now serves as the CEO of both organizations. 

Marna chairs the boards of the Healthcare Institute and the Coalition to Protect America’s Healthcare and is the past chair of Vizient, a Dallas, Texas-based healthcare company. She serves on several other boards including the Connecticut Hospital Association and New Haven Promise. 

Marna has been the recipient of several awards recognizing her advocacy and community involvement including the AHA Grassroots Champion Award, the Anti- Defamation League Torch of Liberty Award, The Greater New Haven Chamber of Commerce Community Leadership Award and Business New Haven Business Person of the Year. She was awarded an honorary Doctor of Humane Letters by Quinnipiac University and a Doctor of Business Administration by the University of New Haven. She received her undergraduate degree from Stanford University and was awarded a Master’s of Public Health by Yale School of Public Health. 

A faculty member at the Yale School of Public Health and Foundation for Professional Development in South Africa since 2005, Marguerite Callaway has developed and delivered online and face-to-face leadership development and management training globally. She has collaborated with the YSPH Global Health Leadership Institute’s programs in both China and South Africa.

Ms. Callaway’s life’s work has been to understand the conditions that foster leadership effectiveness and organizational success. She’s a recognized expert in leadership development, systems thinking and strategic management and human motivation in work settings. She has served on several company boards, and is a frequent speaker in domestic and international settings. She has written three books and is the Founder/President of Callaway Companies, which includes an international leadership development and management training company, an international management consultancy focused on the healthcare segment, and a multimedia communications production company. Her client roster includes companies in forty-six states in the USA, the UK, four African countries and China.

Teresa Chahine is the inaugural Sheila and Ron ’92 Marcelo Lecturer in Social Entrepreneurship at the Yale School of Management. She is the author of "Introduction to Social Entrepreneurship," a twelve step framework for building impactful ventures in new and existing organizations. Dr. Chahine's research focuses on developing tools to characterize and advance social and environmental determinants of health. She launched the first social entrepreneurship program in the context of public health, at Harvard University. She was also responsible for launching the first venture philanthropy organization in her home country of Lebanon, providing tailored financing and critical management support to social enterprises serving marginalized populations through education and job creation for youth and women.

Dr. Chahine has published widely on financing, measuring, and scaling social impact. She has worked on social innovation and sustainable development within corporate, governmental, academic and non-profit organizations. Among these are the United States Environmental Protection Agency, United Nations Populations Fund, Lebanese Ministry of Social Affairs, Malaysian Directors Academy, Sichuan University, Kazakhstan School of Public Health, and Amani Institute in Brazil. She was the recipient of the Harvard Humanitarian Initiative's inaugural Elizabeth T. Weintz humanitarian research award in 2016 and the Harvard T.H. Chan School of Public Health's emerging leader in public health award in 2017.

Mr. D'Aquila received his graduate degree in hospital administration from Yale School of Medicine and his bachelor’s degree in economics from Central Connecticut State University. Before joining Yale-New Haven Hospital in 2006, he was a senior vice president and chief operating officer of New York Presbyterian Hospital/Weill Cornell Medical Center. Previously, D’Aquila was executive vice president and chief operating officer at St. Vincent’s Medical Center in Bridgeport.

Martha works with the Yale School of Public Health as a lecturer in health management and as a member of the teaching faculty for the Yale-IMD Hospital Management and Leadership Program based in Beijing, China and New Haven, CT. Ms. Dale most recently has worked at Yale as the director for China programs at the Global Health Leadership Institute (GHLI) of Yale University’s School of Public Health. She had primary responsibility for the Yale-Tsinghua University collaborative with the Goldman Sachs 10,000 Women: Yale-Tsinghua Certificate Program in International Healthcare Management Program. Martha also had been a member of the Leadership Saves Lives project, the Ethiopian Hospital Management Initiative and the Liberian Healthcare Management Program of Yale University and the Clinton Foundation. Prior to her work at Yale, she was the executive director of Leeway, an AIDS-dedicated skilled nursing facility and supportive housing provider. Ms. Dale has also worked at several other Connecticut non-profit organizations, including serving as the executive director of Woodlake at Tolland nursing facility, executive director of Duncaster lifecare community and vice president of Hartford Hospital. She currently serves on the board of Grace Cottage Hospital in Townsend, VT.

Henry G. Dove, Ph.D. received an MBA from the University of California at Berkeley and his doctorate in operations research/health services research from the Yale University School of Management.

He is the former director of Yale University-West Haven Veterans Health Services Research program; his research focused on innovative methods for quality assurance.

He was a founding officer of Iris Corporation, a startup company that developed software products for

• Assisting hospitals in conducting utilization review, discharge planning, concurrent DRG assignment, infection control, and operating room analyses
• Profiling physicians’ treatment patterns for utilization review and quality improvement.

He is currently president of Case-mix Analytics, LLC which conducts specialized analyses based on provider payment systems used by Medicare, Medicaid and private insurers. Its engagements usually involve huge datasets, various patient classification/severity adjustment systems {DRGs, RBRVS, APR-DRGs}, applied statistical methods and financial modeling to analyze utilization patterns, costs and health care quality. Its clients are hedge funds, private equity firms and health care providers. Other projects have employed cost-effectiveness, Markov and discrete event simulation models.

Dr. Dove has taught quantitative courses in health care finance and management science for more than 25 years at the Yale School of Public Health’s Department of Health Policy & Management, where he has won three teaching awards.

Some of his other honors include author of “Best Article of The Year” — awarded by Disease Management Association of America (2003, with I. Duncan); “Distinguished Teacher of the Year,” Yale School of Public Health (1994); Finalist, American College of Medical Practice Executives & Medical Group Management Association (2006); Health Insurance Association of America Faculty Fellow (1992); “Gerson-Lehrman Scholar”; and Guidepoint Global Health Care Finance Expert.

Current Interests

• Patient Classification Systems for Reimbursement and Outcomes Assessment.
• Risk Adjustment Systems for Paying and Evaluating Health Plans and Providers
• Forecasting the Impact of Medicare Payment System Changes on Health Care Providers’ Profitability
• Disease Modeling (Markov models and cost-effectiveness analyses for clinical decision-making and evaluating medical devices and pharmaceutical agents)
• Evaluating Disease Management and Wellness Programs.

Dr. Hamblin is board certified in public health and general preventive medicine. He is a staff writer at The Atlantic magazine, where he also served for six years as a senior editor. His work has also appeared in The New York Times, Politico, PBS, and Vice. He is the author of If Our Bodies Could Talk (Doubleday, 2016) and a forthcoming book on the skin care industry and skin microbiome, Clean (Riverhead, 2020). He has spoken at TED Med, South by Southwest, Aspen Ideas Festival, National Academies of Sciences, and the Global Ideas Forum. 

Martin Klein, Ph.D., M.P.H. is the Senior Advisor to the dean of the Yale School of Public Health and Director, Executive MPH, an online degree program. He is also the Executive Director of the Yale Center on Climate Change and Health. He founded and directed InnovateHealth Yale, a program in social impact and entrepreneurship, the first program of its kind at a school of public health. He previously served as the Associate Dean for Development and External Affairs at the Yale School of Public Health, and was responsible for the offices of development, alumni relations, and communications. Martin came to the School from Yale’s Graduate School of Arts and Sciences where he was Associate Dean for Student Services and Administrative Operations. Prior to joining Yale, he was the Associate Dean for Primary Care at New York Medical College, where he co-founded and co-led the Center for Primary Care Education and Research. He was an Assistant Professor of Community and Preventive Medicine and taught a variety of topics, including managed care, medical informatics, and physician communication skills. Earlier in his career, Martin held positions with the New York City Mayor’s Office of Management and Budget and the New York City Department of Health. He received his M.P.H. from Yale and his Ph.D. in Sociomedical Sciences from Columbia University. He completed additional training in pedagogy as a Harvard Macy Scholar.

Sanjeev Kumar is a Lecturer of Health Economics and Health Policy at the Department of Health Policy and Management and works in collaboration with the Human Nature Lab at the Yale Institute for Network Science at Yale University. Dr. Kumar received his post-doctoral training at Yale, did his Ph.D. (Economics) from Southern Methodist University (SMU), Texas. Dr. Kumar areas of specialization are health economics and global health. His recent research projects investigate the role that health plays in the formation of risk preference, social networks, crime and incarceration, and political ideology. He has taught undergraduate and graduate level courses—Cost Effectiveness Analysis, Advanced Health Economics, Microeconomic Theory, and Genetics and Economics—at Yale, University of Rwanda, Makelle University (Ethiopia), University of Memphis, and SMU.

Mary Alice Lee is a Lecturer at the Yale School of Public Health. Her research and teaching is focused on improving health and health care for children, pregnant women, and families. For over twenty years, Dr. Lee directed state-funded independent monitoring and policy analysis of enrollment trends, maternal health and birth outcomes, and children’s health services in Connecticut’s HUSKY Program (Medicaid and CHIP). Since 2015, Dr. Lee has worked with colleagues in Bhutan and at the Bhutan Foundation to strengthen health research capacity at the Khesar Gyalpo University of Medical Sciences. In 2014, Dr. Lee was a Lecturer at the Yale University Jackson Institute for Global Affairs. Prior to completing a doctoral degree in epidemiology at Yale University, Dr. Lee was a nurse, nurse-midwife and nurse-midwifery educator.

Erika Linnander directs Yale's Global Health Leadership Initiative, where she develops and leads education and research in health management across country settings. A lecturer at the Yale School of Public Health, Ms. Linnander teaches management, quality improvement, and strategic problem solving across Yale’s certificate and master’s-level education programs. Over the past decade, she has designed, led, and evaluated health management programming in China, Egypt, Ethiopia, Liberia, Rwanda, and South Africa, the United Kingdom, and the United States.

In the US, her research and practice has focused on the creation of effective organizational culture in healthcare (she recently led the design and development the successful “Leadership Saves Lives” intervention to promote organizational culture change in US hospitals). Globally, she has focused on the development of national management and governance systems as leverage points for improving health system performance and population health outcomes. She has supported a number of novel, large-scale mentorship and education programs in health and hospital management, the development of hospital and district-level governing boards, the creation of national quality improvement collaboratives in resource limited settings, and the establishment of national tools and systems to measure and improve hospital and primary care system performance. She currently serves as the principal investigator for Primary Healthcare Transformation Initiative, a multi-year effort to create a culture of performance management and accountability in Ethiopia's district health offices, supported by the Bill & Melinda Gates Foundation.  She also serves as the principal investigator of the Expanded Program on Immunization Leadership and Management Programme (EPI LAMP), a Gavi-funded effort to build leadership and management capacity among teams of senior managers and Ministry officials with responsibility for immunization program performance from across Africa and Asia.

Ms. Linnander also uses innovative implementation science research methods to evaluate prospective interventions to improve health and health equity in and across complex systems within and across country settings. She currently serves as the principal investigator for the USAID-funded mixed-methods evaluation of Project Last Mile (PLM), a multi-country effort to translate the supply chain and logistics expertise of the Coca-Cola system to public sector medical supply chain organizations across Africa.

In addition to her academic expertise and practical experience in global health management, she possesses significant operational experience in hospital settings. Prior to joining the Yale team, she worked in hospital administration at the Johns Hopkins Health System. Ms. Linnander received her MPH from the Johns Hopkins Bloomberg School of Public Health and her MBA from the Johns Hopkins Carey School of Business.

Jeannie Mantopoulos, '08 M.P.H., Resolve To Save Lives, Chief Operating Officer. In this role, she provides leadership and management to promote operational excellence in Resolve’s two components: Resolve to Save 100 Million Lives and Resolve to Prevent Epidemics. Jeannie is a global public health professional with over 10 years of management experience developing strategy, cultivating strong partnerships, and leading programs that are practical, evidence-based, and tailored to specific needs.

Prior to joining Resolve to Save Lives, Jeannie served as Director of Programs for Yale University’s Global Health Leadership Institute, where she was responsible for managing a large global team, grant development, program design, and leading implementation of the institute’s global health initiatives in Africa, Asia, UK, and the US.  Jeannie led the establishment of Yale University’s first country office for field operations and oversaw leadership programs that trained mid- and senior level health professionals in over 20 countries, including the first master’s degree program in healthcare administration in Africa (at Jimma University, Ethiopia).  Jeannie maintains a lectureship appointment with the Yale School of Public Health and is an International Advisory Committee Member for World of Children. Jeannie has a Bachelor of Arts degree in Economics from Hunter College and her Master of Public Health from the Yale School of Public Health.

Zahirah McNatt, MHSA, is a doctoral candidate (DrPH) at the Mailman School of Public Health and a senior research associate with the Syrian Refugee Initiative. Zahirah is currently wrapping up a study focused on the impact of host-country healthcare policy on Syrian refugees residing in urban settings in Jordan. She is also taking on new work aimed at studying the effectiveness of emergency education programs for children in adversity in central and east Africa. Prior to joining the program, Zahirah spent 10 years managing and implementing projects in health and human rights. Most recently, she served as Director for Leadership Education and Practice at Yale’s Global Health Leadership Institute (GHLI). Her role involved the management of research and intervention activities and the facilitation of leadership development programs for various audiences including senior government officials, policy makers and administrators (Tanzania, Rwanda, Ethiopia, Togo, Cambodia). Zahirah spent 3 years in Ethiopia working to improve hospital quality through the creation of degree programs, national quality improvement initiatives and health systems research. She has also worked to develop chronic disease outreach programs and educational opportunities for ministries, NGOs, physicians and administrators. Zahirah supported the development of strategies for improving access to services for people with disabilities who reside in Ethiopia, Tanzania, Sudan and Zambia and has extended this work to South East Asia. Her current interest is in facilitating the creation of innovative and effective approaches to health and education in crisis-affected contexts. Zahirah has a BA from Cornell University and an MHSA from the University of Michigan, School of Public Health.

Dr. Erika Rogan has more than a decade of experience in federal health program evaluation, policy development and analysis, and health services research.  In her consulting roles, Dr. Rogan has provided advisory services for a variety of federal agencies, including the Centers for Medicare and Medicaid Services, the Department of Defense, and the Food and Drug Administration. As a former hospital advocate, she managed policy issues related to Medicare inpatient payment, rural hospitals, and the Medicare Payment Advisory Commission.  

 Dr. Rogan's previous academic research has focused on aging/older adult health policy and the ways in which health care and social services can be coordinated to improve population health. She holds a B.S. in health studies from Georgetown University, a M.Sc. in health policy, planning, and financing from the London School of Economics and the London School of Hygiene & Tropical Medicine, and a Ph.D. in health policy and management from Yale University. In addition to her consulting work, Dr. Rogan is a lecturer at the Yale School of Public Health and an adjunct Assistant Professor at Georgetown University.

Michael Skonieczny is Deputy Director for the Yale Institute for Global Health (YIGH) and Lecturer in Public Health (Health Policy). Mr. Skonieczny was the director of public policy for Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, where he led the organization’s advocacy efforts focused on expanding U.S. financial support for the Global Fund to Fight AIDS, Tuberculosis and Malaria. Prior to Friends, he was a senior public policy officer at the Elizabeth Glaser Pediatric AIDS Foundation, where he focused on global AIDS funding, prevention of mother-to-child transmission, pediatric treatment and related issues. Mr. Skonieczny was also a legislative assistant to Congresswoman Rosa L. DeLauro (D-CT), staffing her on appropriations and health-related issues. He has a B.A. from the Pennsylvania State University and an M.P.A. from George Washington University.

Jonathan is a lecturer in Epidemiology of Microbial Diseases and Global Health at Yale University School of Public Health. His research focuses on infectious disease transmission dynamics, with a focus on TB and HIV among miners and migrants in sub-Saharan Africa. He is an affiliate of the Yale Global Health Leadership Institute and founding director of Visual Epidemiology, a non-profit organization seeking to combine academic discourse with personal narratives through filmmaking.

Dr. Spangler joined the Office of the Provost in 1995 and serves as provostial liaison for the Schools of Medicine, Nursing, and Public Health, Yale University Health Services, the Office of Environmental Health and Safety, and other health and biomedical units. She also oversees the Provost's Office of Academic Integrity, established in 2011, working with colleagues throughout the University to fortify and consolidate programs and procedures relating to academic integrity. Additionally, she is charged with leadership of University-wide Title IX compliance and related initiatives.

Before assuming her present position, Dr. Spangler served as Director of Yale University Health Services, a health care delivery system serving faculty, employees, students, and their dependents. Dr. Spangler did her residency training at Yale-New Haven Hospital and holds an appointment as Clinical Professor in the Yale School of Medicine Department of Obstetrics, Gynecology, and Reproductive Sciences. From 2009 to 2011, she also held the position of Associate Vice President for West Campus Planning.

Dr. Richard Stahl is the senior associate dean for strategic relationships at the Frank H. Netter MD School of Medicine at Quinnipiac University. He had more than 35 years of leadership experience from the Yale New Haven Health System, where he served as vice president for clinical services. While at the Yale New Haven Health System, Stahl served in several leadership roles, including assistant medical director of surgery, the Emergency Department; co-director, Yale Comprehensive Breast Center; associate chief of the Department of Surgery; associate chief of staff; executive director, Perioperative Services; and vice president of the Ambulatory Services Division. He also was a member of the senior operations group.

Stahl earned his medical degree at Vanderbilt University and completed his residency training in general surgery at Yale-New Haven Hospital, where he served as chief resident. He also completed a residency in plastic and reconstructive surgery at Emory University, where he also served as chief resident. He also holds a bachelor's degree from Emory and a MBA from the University of New Haven.

Stahl maintains a clinical practice in plastic and reconstructive surgery in Guilford.

Paul D. Cleary, Ph.D. is the Anna M.R. Lauder Professor Emeritus of public health in the Department of Health Policy and Management. and Dean Emeritus of Public Health.

Dr. Cleary received his Ph.D. in sociology from the University of Wisconsin. His earliest work focused on studies of health behavior. He conducted theoretical and empirical research on smoking as well as patients’ perceptions and responses to physical symptoms and factors affecting use of medical care. He also studied the recognition and management of conditions such as mental illness, alcohol abuse and functional impairment in primary care settings.

For much of his career, Dr. Cleary has been actively involved in research focused on persons infected with HIV. He has investigated the ways in which infection affects people’s lives and the factors affecting the quality of medical care for infected persons. He led a key component of the HIV Costs and Services Utilization Study (HSCUS), in which his team investigated the physician and clinic characteristics that predict the quality of care that patients receive. He also conducted a major national evaluation of a quality improvement program in HIV clinics funded by the Ryan White Care Act.

He has studied how organizational characteristics affect the costs and quality of care for persons with AIDS; evaluated a national continuous quality improvement initiative in clinics providing care to HIV infected individuals; and studied the long-term impact of patient-centered hospital care. He is Principal Investigator of one of the Consumer Assessment of Healthcare Providers and Systems (CAHPS) projects funded by the Agency for Healthcare Research and Quality (AHRQ) to develop information gathering surveys for consumers regarding their health plans and services. He has published more than 350 journal articles describing his research.

Dr. Cleary has been a member of the Academy of Medicine (AOM) since 1994 and served as Chair of two AOM Committees: the Committee on the Ryan White CARE Act: Data for Resource Allocation, Planning and Evaluation in 2002-2003, and the Committee on HIV Screening and Access to Care from 2010 to 2011. He has also been a member of the Connecticut Academy for Science and Engineering since 2007. In 1996, he was selected as a distinguished fellow of the Association for Health Services Research, and in 2002, received the Distinguished Investigator Award from the Academy for Health Services Research and Health Policy. In 2010, Dr. Cleary was awarded the Picker Award for Excellence in the Advancement of Patient-Centered Care by the Picker Institute.  In 2018, he received the L:eo G. Reeder Award for Distinguished Contributions to Medical Sociology.

From 2005 to 2016 Dr. Cleary chaired the National Advisory Committee for The Robert Wood Johnson Foundation Investigator Awards in Health Policy Research Program. He has served as editor of The Milbank Quarterly, associate editor of the Journal of Health and Social Behavior, consulting editor of the Journal of Culture, Medicine and Psychiatry, and an editorial board member of The Handbook of Social Studies in Health and Medicine and the Advanced Handbook of Methods in Evidence Based Health Care.

Sally Horowitz served as head of the Division of Health Policy and Administration and is a professor emeritus of public health. She was among the first to bring rigorous analytic methods to the study of psychosocial influences on the functional outcomes of vulnerable children. Horwitz has also been a leader in transforming her research into improved pediatric practice and policies. Dr. Horwitz has conducted several intervention evaluations including: (1) an evaluation of information technology training and an intensive case management intervention for an HRSA–sponsored Community Access Project grant; (2) 18-month outcomes under Connecticut’s Welfare Reform Experiment; (3) the impact on children’s functioning of a multidimensional assessment designed specifically for children entering foster care; and (4) the effect on diagnosis and management of psychosocial problems by primary care pediatricians of a web-based tool to gather developmental, emotional and behavioral data from parents.

She has been involved in a number of projects examining critical issues in the implementation of evidence-based practices in mental health and child welfare systems, including the IDEAS study and The Adoption of Innovations.

The emeritus C.-E.A. Winslow Professor of Public Health, Jekel’s research focused on teenage pregnancy, outcomes for teenage mothers and their babies, cocaine abuse as well as high fevers in infancy and intrauterine growth retardation. Jekel was director of medical studies and acting head of the Division of Health Services Administration, director of the School of Medicine's Preventive Medicine Residency Program and assistant director of its Robert Wood Johnson Clinical Scholar Program.